Dr. Supriya Joshi is a Gastroenterologist and Hepatologist in Mississauga, Ontario, Canada. After completing her medical degree at Western University, London, Ontario, Dr Supriya Joshi completed residency in Internal Medicine and Gastroenterology at The University of Toronto. Following completion of her GI fellowship she accepted a CIHR sponsored fellowship in Hepatology at The University of Toronto with Dr. Jenny Heathcote. After working at Toronto Western Hospital as a clinical Hepatologist supervising and educating learners in an autoimmune liver disease clinic for 3 years she has since been working solely at The Credit Valley Hospital, Trillium Health Partners in Mississauga, Ontario which is one of the largest community hospitals in Canada. She has a special interest in autoimmune liver disease, viral hepatitis and fatty liver disease. She enjoys speaking and educating others on these topics, especially regarding the incoming volume of fatty liver disease and its impact and management with Hepatology. She is an active member of Canadian Clinicians for Therapeutic Nutrition (CCTN) which is a group aiming to educate Canadians on whole food nutrition as therapy for the epidemic of nutrition induced chronic disease. She has been writing and educating about the negative impact of sugar and poor diet on metabolic health and is actively taking measures to become knowledgeable in Obesity Medicine, which has tremendous overlap in patients with Metabolic Syndrome and NASH. Outside of medicine she is a mom to 3 young kids and enjoys travel, hot yoga and a good HIT class.
Dr. Robert Gish was first in Pharmacy School at the University of Kansas and then obtained his medical degree from the University of Kansas Medical School in Kansas City, Kansas. He completed a 3-year internal medicine residency at the University of California, San Diego, and a 4-year gastroenterology and hepatology fellowship at the University of California, Los Angeles which included transplant medicine.
Dr. Gish is a fellow of the American Association for the Study of Liver Disease, the American
Society of Transplantation and the American College of Physicians.
He has served on the editorial boards of American Journal of Gastroenterology, Hepatology, Journal of Hepatology, Digestive Diseases and Sciences, and Gastroenterology, among many others. He has co-authored a public health policy for liver health in Vietnam focusing on HBV and is also assisting with the development of viral hepatitis health care policies in Georgia, Armenia, and the Philippines. He was a major early contributor to decipherment methods for the detection of hepatitis B and C virus and characterizing its epidemiology and clinical presentation in humans. He was involved in studies that led to the genotypic classification strategies and methods now in use worldwide. He has published more than 700 original articles, review articles, abstracts, and book chapters.
Robert G. Gish, MD, is currently an Adjunct Professor of Medicine at the University of Nevada Schools of Medicine in Las Vegas and in Reno. He serves as an Adjunct Professor of Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD. In addition, he is also Medical Director of the Hepatitis B Foundation in Doylestown, Pennsylvania.
Dr. Giada Sebastiani is Associate Professor of Medicine at McGill University and Clinician Scientist at the Research Institute of McGill University Health Centre in Montreal, Canada. She provides clinical services in the Division of Gastroenterology and Hepatology. She received a medical degree and specialized in internal medicine at the University of Padua, Italy. She had training in clinical and basic research at Harvard Medical School (US), University College of London (UK), University of Bordeaux (France) and Lady Davis Institute for Medical Research (Montreal, Canada). Her work focuses on fatty liver disease, liver fibrosis and non-invasive diagnostic tools in liver disease, with a current focus on at-risk populations, including people living with HIV, diabetics, patients with inflammatory bowel diseases and women with polycystic ovary syndrome. She is author of 94 articles in peer-reviewed journals in the infectious diseases and hepatology fields (including Hepatology, Journal of Hepatology, Clinical Infectious Diseases, Journal of Infectious Diseases, AIDS; h-index=33, total number of citations>4,000), 15 book chapters, 190 conference publications at national and international congresses. She has been invited speaker in 70 international congresses and universities, including European, Asian Pacific, Mexican, Italian and Canadian Associations for the Study of the Liver. She was awarded the prestigious Clinical Research Salary Award from Fonds Recherche Sante Quebec. Other honors include: honorary membership of the Romanian Association for the Study of the Liver; Emerging Stars in Hepatology Award (Asian Pacific Association for the Study of the Liver, 2010); Top 10 cited papers 2006-2008 Award by Journal of Hepatology - European Association for the Study of the Liver. She is funding and steering committee member of the Canadian NASH Network (https://cannash.ca) and the sole North American representative in the guidelines of the prestigious European AIDS Clinical Society.
Cheryl Dayle introduces herself and shares her background.
Dr. Mark Swain introduces himself and shares a bit about his background and the format of his Q&A.